Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

Novocure to Participate in Upcoming Investor Conferences

Business Wire August 25, 2023

Bronstein, Gewirtz & Grossman, LLC Notifies NovoCure Limited (NVCR) Investors With Losses Exceeding $100K of Class Action and to Actively Participate

Newsfile August 19, 2023

Calling All investors in NovoCure Limited (NVCR): Lead Plaintiff Deadline is Today - Contact Bronstein, Gewirtz & Grossman, LLC

Newsfile August 18, 2023

NVCR FINAL DEADLINE TODAY: ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

Newsfile August 18, 2023

NVCR LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving NovoCure Limited

Accesswire August 18, 2023

DEADLINE TODAY: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile August 18, 2023

FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire August 18, 2023

NVCR Investors Have Opportunity to Lead NovoCure Limited Securities Fraud Lawsuit

PR Newswire August 17, 2023

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)

Business Wire August 17, 2023

DEADLINE FRIDAY ALERT: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile August 17, 2023

NVCR FINAL DEADLINE TOMORROW: ROSEN, A LONGSTANDING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

Newsfile August 17, 2023

NVCR LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving NovoCure Limited

Accesswire August 17, 2023

DEADLINE APPROACHING: Berger Montague Advises NovoCure Limited (NVCR) Investors to Inquire About a Securities Fraud Class Action by August 18, 2023

Newsfile August 17, 2023

NVCR LAWSUIT ALERT: Levi & Korsinsky Notifies NovoCure Limited Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire August 17, 2023

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Accesswire August 17, 2023

NOVOCURE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the Firm

Business Wire August 16, 2023

NVCR IMPORTANT DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important August 18 Deadline in Securities Class Action - NVCR

PR Newswire August 16, 2023

NVCR LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving NovoCure Limited

Accesswire August 16, 2023

FRIDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the Firm

Newsfile August 16, 2023

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of NovoCure Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 18, 2023 - (NASDAQ: NVCR)

PR Newswire August 16, 2023